Ultrasonography of the arterial wall: Preclinical detection of atherosclerosis;Exploration echographiques des parois arterielles: Application a la detection d'atherosclerose preclinique

Archives des Maladies du Coeur et des Vaisseaux

Volumn 90, Issue SPEC. ISS. 2, 1997, Pages 7-10

  Simon, A ^a   Gariepy, J ^a   Levenson, J ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; COLESTIPOL; ISRADIPINE; MEVINOLIN; NICOTINIC ACID; NIFEDIPINE; PRAVASTATIN;

ATHEROSCLEROSIS; CONFERENCE PAPER; DIABETES MELLITUS; ECHOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; PROGNOSIS; ARTERIOSCLEROSIS; CALCINOSIS; COMMON CAROTID ARTERY; DRUG EFFECT; ELASTICITY; FEMORAL ARTERY; INTIMA; PATHOLOGY; REVIEW; RISK FACTOR; TUNICA MEDIA;

ARTERIOSCLEROSIS; CALCINOSIS; CAROTID ARTERY, COMMON; ELASTICITY; FEMORAL ARTERY; HUMANS; HYPERTENSION; PROGNOSIS; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 0030971125     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimai plus medial thickness of me arterial wall. A direct measurement with ultrasounds imaging. Circulation 1986 ; 74 : 1399-406.
2. Gariepy J, Massonnau M, Levenson J, Heudes D, Simon A and the PCVMETRA Group. Evidence for in vivo carotid and femoral wall thickening in human hypertension. Hypertension 1993 ; 22: 111-8.
3. Gariepy J, Simon A, Massonneau M, Linhart A, Levenson J and the PCVMETRA Group. Wall thickening of carotid and femoral arteries in males subjects with isolated hypercholesterolemia. Atherosclerosis 1995 ; 113 : 141-51.
4. Gariepy J, Simon A, Massonneau M, Linhart A, Segond P, Levenson J and the PCVMETRA Group. Structural in vivo changes in the carotid and femoral arteries in essential hypertension : echographic assessment of wall thickening and plaque prevalence. Am J Hypertens 1996 ; 9 : 126-36.
5. Poli A, Tremoli E, Colombo A, Sirtori H, Pignoli P, Paoletti R. Intima plus medical thickness of the arterial wall in hypercholesterolemic patients. Atherosclerosis 1988 ; 70 : 253-61.
6. Mégnien JL, Sené V, Jeannin S et al. and the PCVMETRA Group. Coronary calcification and its relation to extracoronary atherosclerosis in asymptomatic hypercholesterolemic mean. Circulation 1992 ; 85 : 1799-807.
7. Simon A, Giral P, Levenson J. Extracoronary atherosclerotic plaque at multiple sites and total coronary calcification deposit in symptomatic men : association with coronary risk profile. Circulation 1995 ; 92 : 1414-21.
8. Mégnien JL, Sene V, Jeanin S et al. Coronary calcification and its relation to extra coronary atherosclerosis in asymptomatic hypercholesterolemic men. Circulation 1992 ; 85 : 1799-807.
9. Blankenhorn DH, Kramsch DK. Reversal of atherosis and sclerosis : the two components of atherosclerosis. Circulation 1989 ; 79: 1-10.
10. Simon A, Levenson J. Use of arterial compliance for evaluation of hypertension. Am J Hypertens 1990 ; 3 : 97-105.
11. Armentano R, Mégnien JL, Simon A, Bellenfant F, Barra J, Levenson J. Effects of hypertension on viscoelasticity of carotid and femoral arteries in humans. Hypertension 1995 ; 26 : 48-54.
12. Celermajer DS, Sorensen KE, Speigelhalter DJ et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992 ; 340 : 111 -20.
13. Filitti V, Giral P, Simon A, Merli I, Del Pino M, Levenson J. Enhanced constriction of the peripheral large artery in response to acute induction of a flow state in human hypercholesterolemia. Arterioscler Thromb 1991 ; 11 : 161-6.
14. Maseri A, L'Abbate A, Barold G et al. Coronary vasospasm as a possible cause of myocardial infarction. N Engl J Med 1978 ; 299 : 1271-7.
15. Salonen J, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991 ; 11 : 245-52.
16. Crouse JR III, Craven TE, Hagaman AP, Bond MG. Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery. Circulation 1995 ; 92 : 1141-7.
17. Detrano RC, Wong ND, Tang W et al. Prognostic significance of cardiac cinefluoroscopy Tor coronary calcific deposits in asymptomatic high risk subjects. J Am Coll Cardiol 1994 ; 24 : 354-8.
18. Chau NP, Simon A, Vilar J, Cabrera-Fischer E, Pithois-Merli I, Levenson J. Active and passive effects of antihypertensive drugs on large artery diameter and elasticity in human essential hypertension. J Cardiovasc Pharmacol 1992 ; 19 : 78-85.
19. Margitic SE, Bond MG, Crouse JR, Furberg CD, Probstfield JL. Progression and regression of carotid atherosclerosis in clinical trials. Arteriosclerosis 1991 ; 11 : 443-51.
20. Bond MG, Strickland HL, Wilmoth SK, Safrit An Phillips R, Szostak L for the MIDAS Research Group. Interventional clinical trials using non-invasive ultrasound end points : the multicenter Isradipine/diuretic atherosclerosis study. J Cardiovasc Pharmacol 1990 ; 15 (suppl 1) : S 30-S 33.
21. Furberg CD, Adams HP, Applegate WB et al. for the Asymptomatic Carotid Artery Progression Study Research Group. Effect of Lovastin on early carotid atherosclerosis and cardiovascular events. Circulation 1994 ; 90 : 1679-87.
22. Crouse JR III, Byington RP, Bond MG et al. Pravastatin, lipids and atherosclerosis in the carotid arteries (PLAC II). Am J Cardiol 1995; 75: 455-9.
23. Blankenhorn DH, Selzer RH, Crawford DW et al. Beneficial effects of colestipol-Niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation 1993 ; 88 : 20-8.
24. Simon A, Gariepy J, Provost JC, Massonneau M, Levenson J on the behalf of the IMT-INSIGHT Group. Nifedipine, hypertensive and arterial wall thickness in extracoronary arteries : Design feature of a clinical trial using non invasive ultrasound end points. J Cardiovasc Pharmacol 1996 ; 28 (suppl 3) : 27-32.
25. Leung WH, Lau CP, Wong CK. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patient. Lancet 1993 ; 341 : 1496-507.
26. Mégnien JL, Simon A, Andriani A, Segond P, Jeannin S, Levenson J. Cholesterol lowering therapy inhibits the low-flow mediated vasoconstriction of the brachial artery in hypercholesterolemic subjects. Br J Clin Pharmacol 1996 ; 42 : 187-93.